CRISPR/Cas Microbial Phenotype Control via Segmented Gene Modules

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current genomic editing technologies, such as CRISPR/Cas, face limitations in precisely and efficiently altering gene expression in microbial organisms, particularly in controlling phenotype changes and repair processes, which are crucial for targeted modifications and functional restoration.

Innovation Solution

Engineered microbial organisms equipped with specific heterologous polynucleotide sequences, including phenotype coding sequences linked to promoters, Cas nuclease, and guide RNA, enable targeted gene alterations and repairs by inducing detectable phenotypes such as color, fluorescence, scent, or antibiotic resistance, using the CRISPR/Cas system in conjunction with lambda red recombineering for precise modifications.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If CRISPR/Cas system is used to induce double-stranded breaks for gene modification, then gene editing capability is improved, but precision and efficiency in controlling phenotype changes deteriorates

Engineering Contradiction:
Improvegene editing capabilityVSAvoidprecision in controlling phenotype changes
Core Design Contradiction:
Adaptability or versatilityVSManufacturing precision

Solution Approach 1:

The system segments the gene editing process into distinct functional modules: Cas nuclease for DNA cleavage, guide RNA for target recognition, and separate phenotype coding sequences for controlled expression. This segmentation allows independent optimization of each component, improving both editing capability and phenotypic control precision.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent incorporates phenotype coding sequences and regulatory elements into the editing construct before delivering it to the cell. This preliminary arrangement ensures that once editing occurs, the phenotypic changes are pre-programmed and controlled, rather than relying on random mutations alone.

Inventive Principle:
Principle #10Preliminary action

2Reliability

If multiple phenotype coding sequences are introduced for targeted modifications, then functional restoration capability is improved, but system complexity increases

Engineering Contradiction:
Improvefunctional restoration capabilityVSAvoidsystem complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The system uses universal regulatory elements (promoters, terminators) that can control multiple different phenotype coding sequences. This multi-functionality allows a single regulatory framework to manage diverse genetic modifications, improving functional restoration while avoiding proportional increases in system complexity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

Multiple phenotype coding sequences are nested within a single polynucleotide construct or plasmid, along with their regulatory elements. This nesting approach consolidates multiple functions into a unified structure, reducing the overall complexity compared to separate constructs for each phenotype.

Inventive Principle:
Principle #7Nested doll (Nesting)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for controlled and efficient alteration of gene expression, enabling the disruption or restoration of specific phenotypes, thereby facilitating precise genetic modifications and visualizing changes in microbial organisms, enhancing the precision and effectiveness of gene editing processes.

Implementation Method 1

The Cas nuclease can specifically induce a DSB at a target genomic locus through the use of a guide nucleic acid that targets the genomic locus

Methodology Applied
Scientific EffectCRISPR/Cas gene targeting:

Implementation Method 2

each of the first and the second detectable phenotypes is a detectable color, fluorescence, scent, enzymatic activity, antibiotic resistance, morphology or lethality

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentEP3728581B1Controlling phenotype of organisms with crispr/cas gene targeting
Publication Date: 2024.10.09 BIO RAD LABORATORIES INC
  • EP3728581B1 patent drawingFigure 1
  • EP3728581B1 patent drawingFigure 2
  • EP3728581B1 patent drawingFigure 3

AI summary

Engineered microbial organisms for altering gene expression are provided. In some embodiments, the engineered microbial organism comprises: one or more heterologous polynucleotide sequence comprising a phenotype coding sequence operably linked to a promoter; a heterologous polynucleotide sequence comprising an inducible promoter operably linked to a polynucleotide encoding a Cas nuclease; and a heterologous polynucleotide sequence comprising a guide RNA (gRNA) that targets the phenotype coding sequence.